Employer Coverage for GLP-1 Weight Loss Drugs: Trends and Challenges
As the utilization of glucagon-like peptide-1 receptor agonists surges across the United States, some corporate employers and health insurers are rolling back insurance coverage for weight-loss indications. According to a ... Read More